Որոնման արդյունքները - Gerd Horneff
- Ցուցադրվում են 1 - 20 արդյունքները 64
- Գնացեք Հաջորդ էջ
-
1
-
2
Etanercept and uveitis in patients with juvenile idiopathic arthritis Heinrike Schmeling, Gerd Horneff
Հրապարակվել է 2005Artigo -
3
-
4
-
5
Baricitinib in therapy of COPA syndrome in a 15-year-old girl Sophia Krutzke, Christoph Rietschel, Gerd Horneff
Հրապարակվել է 2019Artigo -
6
Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still’s disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker fo... Holger Kudela, Susanne Drynda, Anke Lux, Gerd Horneff, Joern Kekow
Հրապարակվել է 2019Artigo -
7
-
8
OP0196 Changing patterns of juvenile idiopathic arthritis patients treated with etanercept from 2000 to 2016 in the german biker registry population Gerd Horneff, Kirsten Minden, Ivan Foeldvari, Gerd Ganser, Johannes‐Peter Haas, J. Brunner, Ingrid Becker
Հրապարակվել է 2017Artigo -
9
-
10
-
11
Protocols on classification, monitoring and therapy in children’s rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis Gerd Horneff, Ariane Klein, Gerd Ganser, Michaela Sailer‐Höck, Annette Günther, Ivan Foeldvari, Frank Weller‐Heinemann
Հրապարակվել է 2017Revisão -
12
-
13
A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis‐Related Arthritis Rubén Burgos‐Vargas, Shirley M. L. Tse, Gerd Horneff, Aileen L. Pangan, Jasmina Kalabic, Sandra Goss, Kristina Unnebrink, J. Anderson
Հրապարակվել է 2015Artigo -
14
THU0507 Long-term experience with adalimumab for the treatment of juvenile idiopathic arthritis. 5- year data from the german biker registry Ariane Klein, Kirsten Minden, Ivan Foeldvari, Gerd Ganser, Johannes‐Peter Haas, Ralf Trauzeddel, Anton Hospach, Frank Weller‐Heinemann, Gerd Horneff
Հրապարակվել է 2017Artigo -
15
The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception... Claudia Sengler, Jens Klotsche, Martina Niewerth, Ina Liedmann, Dirk Föll, Arnd Heiligenhaus, Gerd Ganser, Gerd Horneff, Johannes‐Peter Haas, Kirsten Minden
Հրապարակվել է 2015Artigo -
16
Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab Gerd Horneff, Ariane Klein, Jens Klotsche, Kirsten Minden, Hans-Iko Huppertz, Frank Weller‐Heinemann, Jasmin Kuemmerle‐Deschner, Johannes‐Peter Haas, Anton Hospach
Հրապարակվել է 2016Artigo -
17
Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry Gerd Horneff, Anna Carina Schulz, Jens Klotsche, Anton Hospach, Kirsten Minden, Ivan Foeldvari, Ralf Trauzeddel, Gerd Ganser, Frank Weller‐Heinemann, J.-P. Haas
Հրապարակվել է 2017Artigo -
18
Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn's Disease Gerd Horneff, Marieke M.B. Seyger, Dilek Arikan, Jasmina Kalabic, J. Anderson, Andreas Lazar, David Williams, Chen Wang, R. Tarzynski-Potempa, Jeffrey S. Hyams
Հրապարակվել է 2018Artigo -
19
Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement Gerd Horneff, Sigrid Fitter, Ivan Foeldvari, Kirsten Minden, Jasmin Kuemmerle‐Deschner, Nicolay Tzaribacev, A. Thon, Michael Borte, Gerd Ganser, Rolf Trauzeddel, Hans‐Iko Huppertz
Հրապարակվել է 2012Artigo -
20
Diversity, functionality, and stability of the T cell repertoire derived <i>in vivo</i> from a single human T cell precursor Philippe Bousso, V. Wahn, Iyadh Douagi, Gerd Horneff, Christophe Pannetier, Françoise Le Deist, Fred Zepp, Tim Niehues, Philippe Kourilsky, Alain Fischer, Geneviève de Saint Basile
Հրապարակվել է 2000Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Medicine
Internal medicine
Arthritis
Rheumatology
Disease
Rheumatoid arthritis
Biology
Genetics
Pediatrics
Juvenile
Etanercept
Adverse effect
Physical therapy
Surgery
Immunology
Pathology
Cohort
Adalimumab
Gastroenterology
Methotrexate
Alternative medicine
Anakinra
Polyarthritis
Tocilizumab
Canakinumab
Juvenile rheumatoid arthritis
Clinical trial
Environmental health
Placebo
Population